Email this article 
UPPER URINARY TRACT TUMORS: 23-YEAR EXPERIENCE OF A CLINIC
- Authors: Matveev V.B.1, Volkova M.I.1, Afonin S.V.1, Romanov V.A.1
-
Affiliations:
- Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- Issue: Vol 7, No 2 (2011)
- Pages: 39-45
- Section: DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER
- Published: 30.06.2011
- URL: https://oncourology.abvpress.ru/oncur/article/view/153
- DOI: https://doi.org/10.17650/1726-9776-2011-7-2-39-45
- ID: 153
Cite item
Full Text
Abstract
The only factor that demonstrates its independent influence on overall survival in our series of observations is surgical radicality (p < 0.0001). This conclusion underlines the importance of the quality of surgical treatment for the prognosis of the disease. Surgical access and scope should be individually determined by the site, sizes, and hypothetical pathomorphological characteristics of a tumor. Correct choice of surgical tactics serves as a pledge to completely remove all afflicted tissues. The efficiency of neoadjuvant and adjuvant chemotherapy for pelvic and ureteral tumors has not been proven. The additional treatment has failed to affect survival in this study.
About the authors
V. B. Matveev
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: asv2931@yandex.ru
Russian Federation
M. I. Volkova
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: asv2931@yandex.ru
Russian Federation
S. V. Afonin
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: asv2931@yandex.ru
Russian Federation
V. A. Romanov
Department of Urology, N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: asv2931@yandex.ru
Russian Federation
References
Supplementary files
